|
1
|
Wang R: Hydrogen sulfide: The third
gasotransmitter in biology and medicine. Antioxid Redox Signal.
12:1061–1064. 2010. View Article : Google Scholar
|
|
2
|
Li L, Rose P and Moore PK: Hydrogen
sulfide and cell signaling. Annu Rev Pharmacol Toxicol. 51:169–187.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang Z, Yang C, Xiao L, Liao X, Lan A,
Wang X, Guo R, Chen P, Hu C and Feng J: Novel insights into the
role of HSP90 in cytoprotection of H2S against chemical
hypoxia-induced injury in H9c2 cardiac myocytes. Int J Mol Med.
28:397–403. 2011.PubMed/NCBI
|
|
4
|
Zhu YZ, Wang ZJ, Ho P, Loke YY, Zhu YC,
Huang SH, Tan CS, Whiteman M, Lu J and Moore PK: Hydrogen sulfide
and its possible roles in myocardial ischemia in experimental rats.
J Appl Physiol (1985). 102:261–268. 2007. View Article : Google Scholar
|
|
5
|
Ji Y, Pang QF, Xu G, Wang L, Wang JK and
Zeng YM: Exogenous hydrogen sulfide postconditioning protects
isolated rat hearts against ischemia-reperfusion injury. Eur J
Pharmacol. 587:1–7. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bliksøen M, Kaljusto ML, Vaage J and
Stensløkken KO: Effects of hydrogen sulphide on
ischaemia-reperfusion injury and ischaemic preconditioning in the
isolated, perfused rat heart. Eur J Cardiothorac Surg. 34:344–349.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Geng B, Chang L, Pan C, Qi Y, Zhao J, Pang
Y, Du J and Tang C: Endogenous hydrogen sulfide regulation of
myocardial injury induced by isoproterenol. Biochem Biophys Res
Commun. 318:756–763. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen SL, Yang CT, Yang ZL, Guo RX, Meng
JL, Cui Y, Lan AP, Chen PX and Feng JQ: Hydrogen sulphide protects
H9c2 cells against chemical hypoxia-induced injury. Clin Exp
Pharmacol Physiol. 37:316–321. 2010. View Article : Google Scholar
|
|
9
|
Zhuang XD, Hu X, Long M, Dong XB, Liu DH
and Liao XX: Exogenous hydrogen sulfide alleviates high
glucose-induced cardiotoxicity via inhibition of leptin signaling
in H9c2 cells. Mol Cell Biochem. 391:147–155. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guo R, Lin J, Xu W, Shen N, Mo L, Zhang C
and Feng J: Hydrogen sulfide attenuates doxorubicin-induced
cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells.
Int J Mol Med. 31:644–650. 2013.PubMed/NCBI
|
|
11
|
Li H, Wang Y, Wei C, Bai S, Zhao Y, Li H,
Wu B, Wang R, Wu L and Xu C: Mediation of exogenous hydrogen
sulfide in recovery of ischemic post-conditioning-induced
cardioprotection via down-regulating oxidative stress and
up-regulating PI3K/Akt/GSK-3β pathway in isolated aging rat hearts.
Cell Biosci. 5:112015. View Article : Google Scholar
|
|
12
|
Predmore BL, Kondo K, Bhushan S,
Zlatopolsky MA, King AL, Aragon JP, Grinsfelder DB, Condit ME and
Lefer DJ: The poly-sulfide diallyl trisulfide protects the ischemic
myocardium by preservation of endogenous hydrogen sulfide and
increasing nitric oxide bioavailability. Am J Physiol Heart Circ
Physiol. 302:H2410–H2418. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang XY, Yang CT, Zheng DD, Mo LQ, Lan AP,
Yang ZL, Hu F, Chen PX, Liao XX and Feng JQ: Hydrogen sulfide
protects H9c2 cells against doxorubicin-induced cardiotoxicity
through inhibition of endoplasmic reticulum stress. Mol Cell
Biochem. 363:419–426. 2012. View Article : Google Scholar
|
|
14
|
Jain SK, Bull R, Rains JL, Bass PF, Levine
SN, Reddy S, McVie R and Bocchini JA Jr: Low levels of hydrogen
sulfide in the blood of diabetes patients and
streptozotocin-treated rats causes vascular inflammation? Antioxid
Redox Signal. 12:1333–1337. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Suzuki K, Olah G, Modis K, Coletta C, Kulp
G, Gerö D, Szoleczky P, Chang T, Zhou Z, Wu L, et al: Hydrogen
sulfide replacement therapy protects the vascular endothelium in
hyperglycemia by preserving mitochondrial function. Proc Natl Acad
Sci USA. 108:13829–13834. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ahmad FU, Sattar MA, Rathore HA, Abdullah
MH, Tan S, Abdullah NA and Johns EJ: Exogenous hydrogen sulfide
(H2S) reduces blood pressure and prevents the
progression of diabetic nephropathy in spontaneously hypertensive
rats. Ren Fail. 34:203–210. 2012. View Article : Google Scholar
|
|
17
|
Whiteman M, Gooding KM, Whatmore JL, Ball
CI, Mawson D, Skinner K, Tooke JE and Shore AC: Adiposity is a
major determinant of plasma levels of the novel vasodilator
hydrogen sulphide. Diabetologia. 53:1722–1726. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peake BF, Nicholson CK, Lambert JP, Hood
RL, Amin H, Amin S and Calvert JW: Hydrogen sulfide preconditions
the db/db diabetic mouse heart against ischemia-reperfusion injury
by activating Nrf2 signaling in an Erk-dependent manner. Am J
Physiol Heart Circ Physiol. 304:H1215–H1224. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao Y, Yao X, Zhang Y, Li W, Kang K, Sun L
and Sun X: The protective role of hydrogen sulfide in myocardial
ischemia-reperfusion-induced injury in diabetic rats. Int J
Cardiol. 152:177–183. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu W, Chen J, Lin J, Liu D, Mo L, Pan W,
Feng J, Wu W and Zheng D: Exogenous H2S protects H9c2
cardiac cells against high glucose-induced injury and inflammation
by inhibiting the activation of the NF-κB and IL-1β pathways. Int J
Mol Med. 35:177–186. 2015.
|
|
21
|
Zhou X, An G and Lu X: Hydrogen sulfide
attenuates the development of diabetic cardiomyopathy. Clin Sci
(Lond). 128:325–335. 2015. View Article : Google Scholar
|
|
22
|
Piper PW: The Hsp90 chaperone as a
promising drug target. Curr Opin Investig Drugs. 2:1606–1610.
2001.
|
|
23
|
Terasawa K, Minami M and Minami Y:
Constantly updated knowledge of Hsp90. J Biochem. 137:443–447.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kupatt C, Dessy C, Hinkel R, Raake P,
Daneau G, Bouzin C, Boekstegers P and Feron O: Heat shock protein
90 transfection reduces ischemia-reperfusion-induced myocardial
dysfunction via reciprocal endothelial NO synthase serine 1177
phosphorylation and threonine 495 dephosphorylation. Arterioscler
Thromb Vasc Biol. 24:1435–1441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiao JD, Garg V, Yang B and Hu K: Novel
functional role of heat shock protein 90 in ATP-sensitive
K+ channel-mediated hypoxic preconditioning. Cardiovasc
Res. 77:126–133. 2008. View Article : Google Scholar
|
|
26
|
Mohan S, Konopinski R, Yan B, Centonze VE
and Natarajan M: High glucose-induced IKK-Hsp-90 interaction
contributes to endothelial dysfunction. Am J Physiol Cell Physiol.
296:C182–C192. 2009. View Article : Google Scholar :
|
|
27
|
Vladic N, Ge ZD, Leucker T, Brzezinska AK,
Du JH, Shi Y, Warltier DC, Pratt PF Jr and Kersten JR: Decreased
tetrahydrobiopterin and disrupted association of Hsp90 with eNOS by
hyperglycemia impair myocardial ischemic preconditioning. Am J
Physiol Heart Circ Physiol. 301:H2130–H2139. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tay AS, Hu LF, Lu M, Wong PT and Bian JS:
Hydrogen sulfide protects neurons against hypoxic injury via
stimulation of ATP-sensitive potassium channel/protein kinase
C/extracellular signal-regulated kinase/heat shock protein 90
pathway. Neuroscience. 167:277–286. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jha S, Calvert JW, Duranski MR,
Ramachandran A and Lefer DJ: Hydrogen sulfide attenuates hepatic
ischemia-reperfusion injury: Role of antioxidant and antiapoptotic
signaling. Am J Physiol Heart Circ Physiol. 295:H801–H806. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Meng JL, Mei WY, Dong YF, Wang JH, Zhao
CM, Lan AP, Yang CT, Chen PX, Feng JQ and Hu CH: Heat shock protein
90 mediates cytoprotection by H2S against chemical
hypoxia-induced injury in PC12 cells. Clin Exp Pharmacol Physiol.
38:42–49. 2011. View Article : Google Scholar
|
|
31
|
Dummler B and Hemmings BA: Physiological
roles of PKB/Akt isoforms in development and disease. Biochem Soc
Trans. 35:231–235. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Semple D, Smith K, Bhandari S and Seymour
AM: Uremic cardiomyopathy and insulin resistance: A critical role
for akt? J Am Soc Nephrol. 22:207–215. 2011. View Article : Google Scholar
|
|
33
|
Yu Q, Gao F and Ma XL: Insulin says NO to
cardiovascular disease. Cardiovasc Res. 89:516–524. 2011.
View Article : Google Scholar
|
|
34
|
Laviola L, Belsanti G, Davalli AM, Napoli
R, Perrini S, Weir GC, Giorgino R and Giorgino F: Effects of
streptozocin diabetes and diabetes treatment by islet
transplantation on in vivo insulin signaling in rat heart.
Diabetes. 50:2709–2720. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gurusamy N, Watanabe K, Ma M, Prakash P,
Hirabayashi K, Zhang S, Muslin AJ, Kodama M and Aizawa Y: Glycogen
synthase kinase 3beta together with 14-3-3 protein regulates
diabetic cardiomyopathy: Effect of losartan and tempol. FEBS Lett.
580:1932–1940. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jeon YK, Park CH, Kim KY, Li YC, Kim J,
Kim YA, Paik JH, Park BK, Kim CW and Kim YN: The heat-shock protein
90 inhibitor, geldanamycin, induces apoptotic cell death in
Epstein-Barr virus-positive NK/T-cell lymphoma by Akt
down-regulation. J Pathol. 213:170–179. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li X, Luo R, Jiang R, Meng X, Wu X, Zhang
S and Hua W: The role of the Hsp90/Akt pathway in myocardial
calpain-induced caspase-3 activation and apoptosis during sepsis.
BMC Cardiovasc Disord. 13:82013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Manna P and Jain SK: Hydrogen sulfide and
L-cysteine increase phosphatidylinositol 3,4,5-trisphosphate (PIP3)
and glucose utilization by inhibiting phosphatase and tensin
homolog (PTEN) protein and activating phosphoinositide 3-kinase
(PI3K)/serine/threonine protein kinase (AKT)/protein kinase Cζ/λ
(PKCζ/λ) in 3T3l1 adipocytes. J Biol Chem. 286:39848–39859. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yao LL, Huang XW, Wang YG, Cao YX, Zhang
CC and Zhu YC: Hydrogen sulfide protects cardiomyocytes from
hypoxia/reoxygenation-induced apoptosis by preventing
GSK-3beta-dependent opening of mPTP. Am J Physiol Heart Circ
Physiol. 298:H1310–H1319. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen J, Guo R, Yan H, Tian L, You Q, Li S,
Huang R and Wu K: Naringin inhibits ROS-activated MAPK pathway in
high glucose-induced injuries in H9c2 cardiac cells. Basic Clin
Pharmacol Toxicol. 114:293–304. 2014. View Article : Google Scholar
|
|
41
|
Chen PM, Wu TC, Wang YC, Cheng YW, Sheu
GT, Chen CY and Lee H: Activation of NF-κB by SOD2 promotes the
aggressiveness of lung adenocarcinoma by modulating NKX2-1-mediated
IKKβ expression. Carcinogenesis. 34:2655–2663. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Armstrong SC: Protein kinase activation
and myocardial ischemia/reperfusion injury. Cardiovasc Res.
61:427–436. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bae S and Zhang L: Gender differences in
cardioprotection against ischemia/reperfusion injury in adult rat
hearts: Focus on Akt and protein kinase C signaling. J Pharmacol
Exp Ther. 315:1125–1135. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chen JX and Meyrick B: Hypoxia increases
Hsp90 binding to eNOS via PI3K-Akt in porcine coronary artery
endothelium. Lab Invest. 84:182–190. 2004. View Article : Google Scholar
|
|
45
|
Chanoit G, Lee S, Xi J, Zhu M, McIntosh
RA, Mueller RA, Norfleet EA and Xu Z: Exogenous zinc protects
cardiac cells from reperfusion injury by targeting mitochondrial
permeability transition pore through inactivation of glycogen
synthase kinase-3beta. Am J Physiol Heart Circ Physiol.
295:H1227–H1233. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Jubair S, Li J, Dehlin HM, Manteufel EJ,
Goldspink PH, Levick SP and Janicki JS: Substance P induces
cardioprotection in ischemia-reperfusion via activation of AKT. Am
J Physiol Heart Circ Physiol. 309:H676–H684. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhuo Y, Chen PF, Zhang AZ, Zhong H, Chen
CQ and Zhu YZ: Cardioprotective effect of hydrogen sulfide in
ischemic reperfusion experimental rats and its influence on
expression of survivin gene. Biol Pharm Bull. 32:1406–1410. 2009.
View Article : Google Scholar : PubMed/NCBI
|
